- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
Developing drugs to combat or cure human disease often involves a phase of testing with mice, so being able to peer clearly into a living mouse's innards has real value. But with the fluorescent dyes currently used to image the interior of laboratory mice, the view becomes murky a few millimeters under the skin. Now, however, a team of investigators from Stanford University has developed an improved imaging method using fluorescent carbon nanotubes that create color images centimeters beneath the skin with far more clarity than conventional dyes provide. For a creature the size of a mouse, a few centimeters makes a great difference.
"We have already used similar carbon nanotubes to deliver drugs to treat cancer in laboratory testing in mice, but you would like to know where your delivery went, right?" said Stanford University's Hongjie Dai, a member of the National Cancer Institute's Alliance for Nanotechnology in Cancer. "With the fluorescent nanotubes, we can do drug delivery and imaging simultaneously - in real time - to evaluate the accuracy of a drug in hitting its target." Dr. Dai and his collaborators published their findings in the Proceedings of the National Academy of Sciences.
Dr. Dai's team injects the single-walled carbon nanotubes into a mouse and then watches as the tubes are delivered to internal organs by the bloodstream. The nanotubes fluoresce brightly in response to the light of a laser directed at the mouse, while a camera attuned to the nanotubes' near-infrared wavelengths records the images. By attaching the nanotubes to an anticancer agent, researchers can see how the drug is progressing through the mouse's body.
The key to the nanotubes' usefulness is that they shine in a different portion of the near-infrared spectrum than most dyes. Biological tissues - whether mouse or human - naturally fluoresce at wavelengths below 900 nanometers, which is in the same range as the available biocompatible organic fluorescent dyes. That results in undesirable background fluorescence, which muddles the images when dyes are used. But the nanotubes used by Dai's group fluoresce at wavelengths between 1,000 and 1,400 nanometers.Â There is barely any natural tissue fluorescence at those wavelengths, so background "noise" is minimal.
The nanotubes' usefulness is further boosted because tissue scatters less light in the longer wavelength region of the near-infrared, reducing image smearing as light moves or travels through the body. "The nanotubes fluoresce naturally, but they emit in a very oddball region," Dr. Dai said. "There are not many things - living or inert - that emit in this region, which is why it has not been explored very much for biological imaging." By selecting single-walled carbon nanotubes with different diameters and other properties, Dr. Dai and his team can fine-tune the wavelength at which the nanotubes fluoresce.
The nanotubes can be seen immediately upon injection into the bloodstream of mice. In fact, the Stanford team was able to see the fluorescent nanotubes passing through the lungs and kidneys within seconds of injection.Â The spleen and liver lit up a few seconds later. "You can really see things that are deep inside or blocked by other organs such as the pancreas," Dr. Dai said.
There are other imaging methods that can produce deep tissue images, such as magnetic resonance imaging (MRI) and computer tomography (CT) scans, but fluorescence imaging is widely used in research and requires simpler machinery. Dr. Dai said that the fluorescent nanotubes are not capable of reaching the depth of CT or MRI scans, but represent a step forward in broadening the potential uses of fluorescence as an imaging system beyond the surface and near-surface. "I did not imagine [carbon nanotubes] could really be used in animals to get deep images like these," he said. "When you look at images like this, you get a sense that the body almost has some transparency to it."
About The National Cancer Institute (NCI)
To help meet the goal of reducing the burden of cancer, the National Cancer Institute (NCI), part of the National Institutes of Health, is engaged in efforts to harness the power of nanotechnology to radically change the way we diagnose, treat and prevent cancer.
The NCI Alliance for Nanotechnology in Cancer is a comprehensive, systematized initiative encompassing the public and private sectors, designed to accelerate the application of the best capabilities of nanotechnology to cancer.
Currently, scientists are limited in their ability to turn promising molecular discoveries into benefits for cancer patients. Nanotechnology can provide the technical power and tools that will enable those developing new diagnostics, therapeutics, and preventives to keep pace with today’s explosion in knowledge.
For more information, please click here
National Cancer Institute
Office of Technology & Industrial Relations
ATTN: NCI Alliance for Nanotechnology in Cancer
Building 31, Room 10A49
31 Center Drive , MSC 2580
Bethesda , MD 20892-2580
Copyright © The National Cancer Institute (NCI)If you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
News and information
Leti Announces Launch of First European Nanomedicine Characterisation Laboratory: Project Combines Expertise of 9 Partners in 8 Countries to Foster Nanomedicine Innovation and Facilitate Regulatory Approval July 1st, 2015
Producing spin-entangled electrons July 2nd, 2015